Post Profile






CT Perfusion Technology Monitors Blood Flow to Predict Ovarian Cancer Treatment Response

Patients with advanced ovarian cancer have a very high relapse rate following primary treatment, with 60 to 85% of patients relapsing.  Treatment planning is an important factor in patient care, but few reliable options exist to help physicians accurately plan treatment and select patients who are appropriate candidates for a specific therapy. Researchers from the […]
read more

share

Related Posts


New Blood Test Predicts Breast Cancer Relapse Months in Advance (VIDEO)

Industries / Medical : medGadget

Researchers from The Institute of Cancer Research in London have developed a new blood test, or a so-called liquid biopsy, that can detect breast cancer relapse months in advance compared to traditional scans. The technology, publis...

Blood test may give early warning of skin cancer relapse

Academics / General Science : ScienceDaily: Science Society

A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study. Researchers found that they could see whether a patient was relapsing by tracking levels of ...

New 'mutation-tracking' blood test could predict breast cancer relapse months in advance

Academics / General Science : ScienceDaily: Science Society

Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumors are visible on hospital scans.The test can uncover small numbers of residual cancer...

CT technology shows how blood flow can predict effectiveness of ovarian cancer treatment

Academics / General Science : EurekAlert: Technology Engineering

(University of Western Ontario) Technology developed at Western University and Lawson Health Research Institute can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer. A multi-c...

CT technology shows how blood flow can predict effectiveness of ovarian cancer treatment

Diseases & Conditions / Cancer : ScienceDaily: Cancer

Technology can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer. A multi-center clinical trial has demonstrated that CT Perfusion, which measures blood flow and blood volume t...

Comments


Copyright © 2016 Regator, LLC